N. Ikeda, M. Inoue, H. Iso, S. Ikeda, T. Satoh, M. Noda, T. Mizoue, H. Imano, E. Saito, K. Katanoda and 5 other author(s). PLoS medicine, 9 (1):
e1001160(January 2012)6526<m:linebreak></m:linebreak>JID: 101231360; OID: NLM: PMC3265534; 2011/07/28 received; 2011/12/06 accepted; 2012/01/24 epublish; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
G. Liew, P. Mitchell, T. Wong, E. Rochtchina, and J. Wang. JAMA internal medicine, 173 (4):
258-64(February 2013)JID: 101589534; ppublish;<m:linebreak></m:linebreak>
<m:linebreak></m:linebreak>Causalitat; Exemple.
C. Roumie, E. Mitchel, L. Kaltenbach, P. Arbogast, P. Gideon, and M. Griffin. Stroke; a journal of cerebral circulation, 39 (7):
2037-45(July 2008)4450<m:linebreak></m:linebreak>PUBM: Print-Electronic; JID: 0235266; 0 (Anti-Inflammatory Agents, Non-Steroidal); 0 (Cyclooxygenase 2 Inhibitors); 2008/04/24 aheadofprint; ppublish;<m:linebreak></m:linebreak>New-user designs.
J. Tsai, S. Grosse, A. Grant, N. Reyes, W. Hooper, and H. Atrash. PloS one, 7 (7):
e34048(January 2012)6773<br/>JID: 101285081; 2012/02/22 received; 2012/05/16 accepted; 2012/07/06 epublish; ppublish;<br/>Recerca clínica; CMBD; Exemple.
F. de Vries, C. de Vries, C. Cooper, B. Leufkens, and T. van Staa. International journal of epidemiology, 35 (5):
1301-8(October 2006)4268<m:linebreak></m:linebreak>PUBM: Print; JID: 7802871; 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors); CIN: Int J Epidemiol. 2006 Oct;35(5):1308-9. PMID: 17053012; CIN: Int J Epidemiol. 2006 Oct;35(5):1310-1. PMID: 17053013; CIN: Int J Epidemiol. 2006 Oct;35(5):1312-3. PMID: 17053014; ppublish;<m:linebreak></m:linebreak>New-user designs; Mesures d'associació.
T. Itatsu, A. Nagahara, M. Hojo, A. Miyazaki, T. Murai, M. Nakajima, and S. Watanabe. Internal medicine (Tokyo, Japan), 50 (7):
713-7(January 2011)JID: 9204241; 0 (Serotonin Uptake Inhibitors); 2011/04/01 epublish; ppublish; Confusió absoluta entre cas-control i exposats-no exposats<br/><br/><br/>Tipus d'estudis.
J. Donzé, D. Aujesky, D. Williams, and J. Schnipper. JAMA internal medicine, 173 (8):
632-8(April 2013)7278<br/>JID: 101589534; aheadofprint; SO: JAMA Intern Med. 2013 Mar 25:1-7. doi: 10.1001/jamainternmed.2013.3023.;<br/>Models predictius; Proves diagnòstiques.
J. Delaney, S. Daskalopoulou, and S. Suissa. Pharmacoepidemiology and drug safety, 18 (1):
1-6(January 2009)5076<m:linebreak></m:linebreak>JID: 9208369; 0 (Adrenergic beta-Antagonists); ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Marginal structural models; Exemple.
K. Flegal, B. Graubard, and D. Williamson. American journal of epidemiology, 160 (4):
331-8(August 2004)4391<m:linebreak></m:linebreak>LR: 20041117; PUBM: Print; JID: 7910653; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
B. Miladinovic, A. Kumar, R. Mhaskar, S. Kim, R. Schonwetter, and B. Djulbegovic. PloS one, 7 (10):
e47804(January 2012)6965<m:linebreak></m:linebreak>JID: 101285081; 2012/05/11 received; 2012/09/21 accepted; 2012/10/17 epublish; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Avaluació de riscs.